Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 18/20 | 0.58 |
| ▸ | TNF | P01375 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7943382 | 0.86 | ADAM17 (0.60) | ADAM17TNFKDM4EALDH1A1CYP1A2 | |
| SCHEMBL7940833 | 0.85 | ADAM17 (0.58) | ADAM17TNF | |
| SCHEMBL5955654 | 0.85 | ADAM17 (0.58) | ADAM17TNFKDM4EALDH1A1CYP1A2 | |
| SCHEMBL7945201 | 0.85 | ADAM17 (0.58) | ADAM17KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL5955508 | 0.84 | ADAM17 (0.55) | ADAM17TNFKDM4EALDH1A1CYP1A2 | |
| SCHEMBL5956220 | 0.83 | ADAM17 (0.54) | ADAM17TNF | |
| SCHEMBL6442206 | 0.82 | ADAM17 (0.56) | ADAM17TNFGAA | |
| SCHEMBL25761822 | 0.81 | ADAM17 (0.56) | ADAM17KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL20553902 | 0.80 | ADAM17 (0.57) | ADAM17KDM4EALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL29662743 | 0.80 | ADAM17 (0.55) | ADAM17TNF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1976849-B1 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | MERCK SHARP & DOHME (US) | 2016-03-09 | — | — | EP | disclosed |
| WO-2007084451-A1 | HYDANTOIN DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISORDERS | SCHERING CORPORATION (US) | 2007-07-26 | — | — | WO | disclosed |